MedPath

NATIONAL INSTITUTE OF MENTAL HEALTH AND NEURO SCIENCES

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

46

Active:1
Completed:21

Trial Phases

4 Phases

Phase 1:3
Phase 2:1
Phase 3:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (42.9%)
Phase 3
2 (28.6%)
Phase 2
1 (14.3%)
Phase 4
1 (14.3%)
No trials found

News

Psychedelic Drug DOI Identifies Neuron to Reduce Anxiety in TIFR Study

Researchers at TIFR have identified a specific neuron in the ventral hippocampus that, when activated, can alleviate anxiety in rodents.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.